News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

Mark Scullion

Advertisement

CEO, Atlas Clinical Research

Articles by Mark Scullion

The Strategic Emergence of Site Networks in Clinical Research

ByGerri Gallagher,Adam Kinsey,Mark Scullion,Samir Shah
October 14th 2024

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.

Advertisement

Latest Updated Articles

  • The Strategic Emergence of Site Networks in Clinical Research
    The Strategic Emergence of Site Networks in Clinical Research

    Published: October 14th 2024 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

2

AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma

3

Managing Operational and Compliance Challenges on Emerging Platforms

4

Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial

5

Tech-Enabled Clinical Trials: Simplifying Complexity, Elevating Experience

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us